Table 5.
Ergocalciferol (N=43) | Placebo (N=45) | |
---|---|---|
Serious Adverse Events | ||
All | 0 | 0 |
Rash | 0 | 0 |
Minor Adverse Events | ||
All | 6 | 6 |
Abdominal discomfort | 5 | 4 |
Dry Mouth | 0 | 1 |
Elevated serum phosphorous | 0 | 1 |
Elevated potassium | 1 | 0 |
Ergocalciferol (N=43) | Placebo (N=45) | |
---|---|---|
Serious Adverse Events | ||
All | 0 | 0 |
Rash | 0 | 0 |
Minor Adverse Events | ||
All | 6 | 6 |
Abdominal discomfort | 5 | 4 |
Dry Mouth | 0 | 1 |
Elevated serum phosphorous | 0 | 1 |
Elevated potassium | 1 | 0 |